Literature DB >> 9856515

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

C A Jones1, G M McQuillan, J W Kusek, M S Eberhardt, W H Herman, J Coresh, M Salive, C P Jones, L Y Agodoa.   

Abstract

This report describes the distribution of serum creatinine levels by sex, age, and ethnic group in a representative sample of the US population. Serum creatinine level was evaluated in the third National Health and Nutrition Examination Survey (NHANES III) in 18,723 participants aged 12 years and older who were examined between 1988 and 1994. Differences in mean serum creatinine levels were compared for subgroups defined by sex, age, and ethnicity (non-Hispanic white, non-Hispanic black, and Mexican-American). The mean serum creatinine value was 0.96 mg/dL for women in the United States and 1.16 mg/dL for men. Overall mean creatinine levels were highest in non-Hispanic blacks (women, 1.01 mg/dL; men, 1.25 mg/dL), lower in non-Hispanic whites (women, 0.97 mg/dL; men, 1.16 mg/dL), and lowest in Mexican-Americans (women, 0.86 mg/dL; men, 1.07 mg/dL). Mean serum creatinine levels increased with age among both men and women in all three ethnic groups, with total US mean levels ranging from 0.88 to 1.10 mg/dL in women and 1.00 to 1.29 mg/dL in men. The highest mean creatinine level was seen in non-Hispanic black men aged 60+ years. In the total US population, creatinine levels of 1.5 mg/dL or greater were seen in 9.74% of men and 1.78% of women. Overall, among the US noninstitutionalized population, 10.9 million people are estimated to have creatinine values of 1.5 mg/dL or greater, 3.0 million have values of 1.7 mg/dL or greater, and 0.8 million have serum creatinine levels of 2.0 mg/dL or greater. Mean serum creatinine values are higher in men, non-Hispanic blacks, and older persons and are lower in Mexican-Americans. In the absence of information on glomerular filtration rate (GFR) or lean body mass, it is not clear to what extent the variability by sex, ethnicity, and age reflects normal physiological differences rather than the presence of kidney disease. Until this information is known, the use of a single cutpoint to define elevated serum creatinine values may be misleading.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856515     DOI: 10.1016/s0272-6386(98)70074-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  104 in total

Review 1.  Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.

Authors:  Joanne Kappel; Piera Calissi
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

Review 2.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 3.  Chronic renal disease.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2002-07-13

4.  Clinical challenges: the intersection of diabetes, chronic kidney disease, and cardiovascular disease.

Authors:  Caitlin M Nass; Kim Reck
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

5.  The care of patients with chronic kidney disease.

Authors:  Annamaria T Kausz; Andrew S Levey
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

6.  Race and kidney disease: the scope of the problem.

Authors:  Keith C Norris; Lawrence Y Agodoa
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

7.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

8.  Prevalence of mild impairment in renal function in a random sample of elders from a biethnic community survey.

Authors:  R D Lindeman; L J Romero; C L Yau; R N Baumgartner; P J Garry
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

9.  Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: comparison with Dutch patients.

Authors:  Paul J M Uitewaal; Alex N Goudswaard; Lielith J Ubink-Veltmaat; Lielith J Ubnik-Veltmaat; Marc A Bruijnzeels; Arno W Hoes; Siep Thomas
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 10.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.